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al., 1998) where it plays a crucial role in the accretion
Valerie Horsley,1,2 Katie M. Jansen,1
Stephen T. Mills,2 and Grace K. Pavlath2,*
1Graduate Program in Biochemistry, Cell, and
Developmental Biology of nuclei and myotube growth (Horsley et al., 2001),
suggesting that NFATc2 is important for the fusion of2 Department of Pharmacology
Emory University cells with the growing myotube. However, the genes
regulated by NFATc2 that control muscle growth areAtlanta, Georgia 30322
unknown.
NFAT proteins regulate the expression of many se-
creted cytokines including IL-4 and IL-13 (Rao et al.,Summary
1997). IL-4 and IL-13 can induce macrophage fusion
(McInnes and Rennick, 1988; DeFife et al., 1997). BothSkeletal muscle formation and growth require the fu-
sion of myoblasts to form multinucleated myofibers of these cytokines are produced primarily by Th2 lym-
phocytes and many of the functions of these cytokinesor myotubes, but few molecules are known to regulate
myoblast fusion in mammals. The transcription factor are redundant due to a shared receptor subunit, IL-4R,
which is expressed in a wide range of tissues (Nelms etNFATc2 controls myoblast fusion at a specific stage
of myogenesis after the initial formation of a myotube al., 1999). We hypothesized that the regulation of cell
fusion may be conserved between macrophages andand is necessary for further cell growth. By examining
genes regulated by NFATc2 in muscle, this study iden- skeletal muscle and asked whether NFATc2 regulates
a secreted cytokine to control muscle cell fusion. Wetifies the cytokine IL-4 as a molecular signal that con-
trols myoblast fusion with myotubes. Muscle cells demonstrate that NFATc2 regulates IL-4 in a subset of
fusing muscle cells and induces muscle growth throughlacking IL-4 or the IL-4 receptor subunit form nor-
mally but are reduced in size and myonuclear number. the IL-4 receptor. Our data suggest that following the
initial fusion of myoblasts to form myotubes, IL-4 acts asIL-4 is expressed by a subset of muscle cells in fusing
muscle cultures and requires the IL-4 receptor sub- a myoblast recruitment factor, leading to further nuclear
addition and increases in myotube size.unit on myoblasts to promote fusion and growth.
These data demonstrate that following myotube for-
mation, myotubes recruit myoblast fusion by secretion Results
of IL-4, leading to muscle growth.
A Protein Secreted by Wild-Type Muscle Cells
Introduction Induces Growth of NFATc2/ Myotubes
Previously, we described a role for NFATc2 in muscle
Skeletal muscle fibers are syncitia that form from the growth following differentiation (Horsley et al., 2001).
fusion of mononucleated myoblasts. Myoblast fusion is After 24 hr in differentiation media (DM), both wild-type
also required for muscle growth (Darr and Schultz, 1989; and NFATc2/ myoblasts have begun myotube forma-
Rosenblatt and Parry, 1992; Phelan and Gonyea, 1997; tion and are indistinguishable in size (Figure 1A). How-
Horsley et al., 2001; Mitchell and Pavlath, 2001), as it ever, after 48 hr in DM, wild-type myotubes are large,
increases the number of nuclei within the myofiber cyto- while NFATc2/ myotubes remain small. This defect in
plasm, allowing each nucleus to regulate more cyto- cell size also correlates with a reduction in myonuclear
plasm (Allen et al., 1999), and causes the muscle cell to number (Horsley et al., 2001). Thus, NFATc2/ myotubes
increase in size. While the regulation of myoblast fusion do not have a defect in the initial formation of a multinu-
is important during embryonic development as well as cleated myotube but rather in the further fusion of cells
in maintenance and repair of adult muscle, the mecha- with myotubes.
nisms by which myoblast fusion is controlled during To regulate cell fusion with the nascent myotube,
myogenesis are largely unknown. NFATc2 may regulate the expression of two types of
Calcium-dependent pathways regulate many aspects molecules: a cell surface molecule that mediates cell
of skeletal myogenesis that contribute to skeletal mus- interaction and/or a secreted factor that recruits cell
cle growth (Delling et al., 2000), including muscle cell fusion. To test the hypothesis that NFATc2 regulates a
fusion (Barnoy et al., 1996; Constantin et al., 1996). One secreted factor, the effect of media conditioned (CM)
signaling pathway activated by calcium involves the nu- by wild-type myotubes on the growth of NFATc2/ myo-
clear factor of activated T cells (NFAT) family of tran- tubes was analyzed. When NFATc2/ muscle cells are
scription factors (Crabtree and Olson, 2002). Activation induced to differentiate in wild-type CM, these cells form
and nuclear translocation of NFAT proteins is controlled large myotubes similar to wild-type cells in DM (Figure
by calcineurin, a calcium-sensitive phosphatase. Sev- 1B). The increased size of NFATc2/ myotubes in CM
eral NFAT isoforms are expressed in skeletal muscle, is correlated with increases in myonuclear number to
but each undergoes activation and nuclear translocation wild-type levels (Figure 1B, bottom left). To rule out that
only at specific stages of myogenesis (Abbott et al., NFATc2/ cells do not release a factor that inhibits
muscle growth, the effect of NFATc2/ CM was tested
on wild-type myotubes. NFATc2/ CM has no effect*Correspondence: gpavlat@emory.edu
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Figure 1. Wild-Type CM Contains a Secreted
Factor Involved in Myotube Growth
(A) Bright field images of wild-type and
NFATc2/ myotubes after 24 and 48 hr in
differentiation media (DM). Bar: 30 m.
(B) NFATc2/ myoblasts were induced to dif-
ferentiate in DM or in wild-type conditioned
media (CM) for 48 hr. Bar: 100 m. The num-
ber of nuclei in individual wild-type and
NFATc2/ myotubes was analyzed after in-
cubation in DM or wild-type CM for 48 hr
(bottom left). Wild-type and NFATc2/ myo-
tubes were treated with NFATc2/ CM for 48
hr and analyzed as described above (bottom
right). Data are mean  standard error of
three independent cell isolates. (*significantly
different, p  0.05).
either on the size (data not shown) or the nuclear number to the IL-4R with lower affinity than IL-4 (Murata et al.,
of wild-type myotubes (Figure 1B, bottom right), sug- 1998).
gesting that the reduced size of NFATc2/ myotubes is IL-4 may lead to increases in myonuclear number by
not due to production of a growth inhibitory factor by enhancing cell proliferation, survival, differentiation, or
these mutant cells. Together, these data suggest that fusion. To determine if IL-4 affects cell proliferation
wild-type CM contains a secreted factor that is not pro- and/or survival, the DNA content of cultures treated with
duced by NFATc2/ muscle cells during myotube vehicle or IL-4 was determined and no significant differ-
growth. Further studies demonstrated that NFATc2 reg- ence is observed (Figure 2B). In addition, no difference
ulates the expression of a secreted protein(s) between is observed in the number of differentiated cells after
5 and 30 kDa that is necessary for nuclear addition and 24 hr of IL-4 treatment in DM (data not shown). To test
muscle growth (data not shown). if IL-4 enhances the overall number of muscle cells that
fuse, the fusion index was determined. The percentage
of total nuclei in myotubes is not different between vehi-IL-4 Is the Factor in CM that Induces Growth
cle or IL-4-treated cells (Figure 2C). These data indicateof NFATc2/ Myotubes
that IL-4 is not a general fusion-promoting factor.Since IL-4 is known to induce the fusion of macrophages
Rather, the increases in myonuclear content observed(McInnes and Rennick, 1988), we hypothesized that IL-4
with IL-4 (Figure 2A) suggest that IL-4 augments themay be the bioactive factor in CM. Initially, the effect of
fusion of cells with myotubes to increase muscle cellexogenous IL-4 on NFATc2/ myotubes was deter-
size.mined. Addition of IL-4 induces NFATc2/ myoblasts
Subsequently, to examine whether IL-4 or IL-13 isto form large myotubes with a dose-dependent increase
responsible for the growth-promoting bioactivity in CM,in the percentage of myotubes with 5 nuclei (Figure
CM was treated with neutralizing antibodies against ei-2A). Concentrations of IL-43 ng/ml result in restoration
ther IL-4 or IL-13. No differences are observed betweenof myonuclear number to wild-type levels. Since the IL-4
untreated CM and CM treated with control IgG antibod-receptor (IL-4R) shares a common subunit, the IL-4R
ies or IL-13 antibodies (Figure 2D). In contrast, treatmentchain, with the IL-13 receptor (Nelms et al., 1999), the
with IL-4 antibodies results in a dose-dependent lossability of IL-13 to induce growth of NFATc2/ myotubes
of the bioactivity. To further test that IL-4 is responsiblewas also tested (Figure 2A). Compared to IL-4, higher
for the bioactivity in the CM, CM from IL-4/ myotubesconcentrations of IL-13 (10 ng/ml) are required to in-
was also tested in the myonuclear number assay.duce the increases in myonuclear number of NFATc2/
NFATc2/ myotubes treated with IL-4/ CM are similarmyotubes to wild-type levels. This difference is consis-
tent with signaling through the IL-4R since IL-13 binds to NFATc2/ myotubes in DM (Figure 2E), indicating
IL-4 Regulates Skeletal Muscle Growth
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Figure 2. IL-4 Is the Component of Wild-Type CM that Enhances Myotube Growth
(A) NFATc2/ myoblasts were treated with vehicle, 5 ng/ml IL-4, or 10 ng/ml IL-13 for 48 hr in differentiation media (DM). Bar: 60 m. Cells
were treated with the indicated doses of IL-4 or IL-13 for 48 hr, and the myotubes were analyzed as in Figure 1B.
(B) The DNA content of NFATc2/ cells treated with vehicle or 5 ng/ml IL-4 was quantified after 48 hr in DM.
(C) The percentage of nuclei within myotubes was calculated in NFATc2/ cultures following treatment with vehicle or 5 ng/ml IL-4 at indicated
times.
(D) NFATc2/ myoblasts were incubated in DM, wild-type conditioned media (CM), or wild-type CM treated with indicated doses of control
IgG, IL-4, or IL-13 antibodies for 48 hr and were analyzed as in Figure 1B. Bar: 60 m.
(E) NFATc2/ myoblasts were treated with DM, wild-type CM, or IL-4/ CM for 48 hr and analyzed as in Figure 1B. Data are mean  standard
error of three independent cell isolates (*significantly different from DM, p  0.05).
that wild-type CM increases the size and nuclear number ures 3A and 3B). Retroviral-mediated expression of
NFATc2 in NFATc2/ myoblasts induces expression ofof NFATc2/ myotubes due to the presence of IL-4.
IL-4 mRNA. These data demonstrate NFATc2 regulates
IL-4 expression in skeletal muscle cells.
NFATc2 Regulates the Expression of IL-4
in Skeletal Muscle
To confirm that IL-4 is expressed by muscle cells and IL-4 Is Expressed by a Subset of Muscle Cells
during Muscle Growthregulated by NFATc2, both RT-PCR and ELISA analyses
were utilized. Both IL-4 mRNA and protein are expressed Next, IL-4 and IL-4R expression were examined during
myogenesis by immunostaining. No IL-4 expression isby wild-type muscle cells, but not NFATc2/ cells (Fig-
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bated with antibodies against IL-4 (Figure 4D). Together,
these data suggest that IL-4 expression is limited to
specific stages of muscle growth.
The receptor for IL-4 consists of the IL-4R subunit
and the c subunit in immune cells or IL-13R1 in non-
lymphoid tissues (Nelms et al., 1999). In addition, a dis-
tinct IL-13 receptor chain, IL-13R2, does not bind IL-4
(Donaldson et al., 1998) but can inhibit IL-4-dependent
signaling (Rahaman et al., 2002). To characterize the
receptor subunits that are expressed in skeletal muscle,
RT-PCR was performed on muscle cells, and mRNA
expression was detected for IL-4R and IL-13R1, but
not c or IL-13R2 (Figure 4E). These data suggest that
the IL-4 receptor in skeletal muscle is comprised of IL-
4R1 and IL-13R1 subunits.
IL-4 and the IL-4R Are Required
for Muscle Growth
To analyze the function of IL-4 and the IL-4R in skeletal
muscle in vivo, myofiber cross-sectional area in IL-4/
and IL-4R/ mice was analyzed and compared to wild-
type. The cross-sectional area of myofibers in TA mus-
cles is significantly reduced in the mutant mice (Figure
5A). In addition, the size distribution of myofibers in theFigure 3. NFATc2 Regulates IL-4 Expression in Skeletal Muscle
Cells TA muscles was examined. IL-4/ and IL-4R/ TA
muscles are characterized by an increase in small myo-(A) IL-4 mRNA expression was examined by RT-PCR in wild-type
and NFATc2/ muscle cells after 24 hr in differentiated media (DM). fibers (2400 m2) and a reduction in large myofibers
Wild-type Th2 cells were included as a control. Representative ethid- (3700 m2) (Figure 5B). Similarly, the soleus muscles
ium bromide staining of agarose gel with three independent muscle of IL-4/ and IL-4R/ mice exhibit an increase in small
cell isolates of each genotype is shown with 18S rRNA as an internal
myofibers with a cross-sectional area 1200 m2 andcontrol.
a decrease in large myofibers (1700 m2). Myonuclear(B) The expression of IL-4 protein was analyzed in wild-type and
number was assayed in soleus muscles (Horsley et al.,NFATc2/ CM by ELISA. Data are mean  standard error of three
independent cell isolates (*significantly different, p  0.05). 2001; Mitchell and Pavlath, 2001) to determine if cell
(C) NFATc2/ myoblasts were infected either with control retrovirus fusion is also defective in these mice. The number of
(Ctrl) or with a retrovirus expressing recombinant NFATc2. IL-4 DAPI-stained nuclei was determined inside of the dys-
mRNA expression was analyzed by RT-PCR after 24 hr in DM. Repre-
trophin-stained sarcolemma (Figure 5C). Myonuclearsentative ethidium bromide staining of agarose gel is shown with
number is decreased in IL-4/ soleus muscles as com-18S rRNA as an internal control. Data are indicative of results from
pared to wild-type (Figure 5C), suggesting that the re-three independent experiments.
duced cross-sectional area of myofibers in IL-4/ mice
results from defects in the ability of muscle cells to fuse
with the myofiber in vivo. These analyses support a roleobserved in muscle cells before differentiation (0 hr in
DM) (Figure 4A). Cells begin expressing IL-4 after 24 hr for IL-4 in the developmental growth of myofibers in vivo.
To analyze the role of IL-4 and the IL-4R in musclein DM, a time when most of the cells are differentiated
and beginning to form nascent myotubes. After 36 hr in growth during regeneration, the cross-sectional area of
regenerating myofibers in the TA of IL-4/ and IL-4R/DM when myotube growth peaks, approximately 35%
of the cells are positive for IL-4. However, once mature mice was measured at different times after injury. At
days 8 and 14 after injury, the cross-sectional area ofmyotubes have formed and growth is reduced (48 hr),
the number of positive cells decreases. With exception regenerating myofibers is not significantly different
among wild-type, IL-4/, or IL-4R/ mice (Figure 5D).of a few mononucleated cells at 24 hr, IL-4 staining is
primarily observed in small myotubes. No staining is However, as further growth of the regenerating myofi-
bers occurs, the mean cross-sectional area of both mu-detected in NFATc2/ cells incubated with IL-4 antibod-
ies or in wild-type cells incubated with secondary anti- tants is decreased compared to wild-type at day 25
after injury. Thus, IL-4/ and IL-4R/ myofibers formbodies alone (Figure 4B). Thus, IL-4 is expressed by a
subset of muscle cells during myogenesis. In contrast, normally during regeneration but have a subsequent
defect in myofiber growth and cannot attain the size ofIL-4R is expressed on all cells (Figure 4C).
The expression of IL-4 during muscle regeneration wild-type myofibers. These data suggest that IL-4 is
important for the growth of myofibers after their initialwas examined also (Figure 4D). At days 8 and 14 after
injury, new myofibers have formed in the injured area, formation.
Myofiber growth is dependent on both nonmuscle andand the majority of muscle growth has not occurred. In
these areas of regeneration, IL-4 is located primarily muscle cell types. To test the hypothesis that the in vivo
defects in growth are muscle-cell intrinsic, we examinedoutside small myofibers (Figure 4D). No staining is ob-
served in sections incubated with secondary antibodies primary IL-4/ and IL-4R/ muscle cells in vitro. After
48 hr in DM, both mutants form myotubes, but thesealone or in regenerating muscles of IL-4/ mice incu-
IL-4 Regulates Skeletal Muscle Growth
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Figure 4. IL-4 Is Expressed by a Subset of Myotubes during Muscle Growth
(A) Representative images of fusing cultures immunostained with an antibody against IL-4 after 24 or 36 hr in differentiation media (DM).
Arrowheads indicate the same cell in both fluorescent and phase images. Bar: 60 m. The percentage of IL-4 positive cells was determined
at the indicated times in three independent experiments.
(B) Images of NFATc2/ cells incubated with antibodies against IL-4 and wild-type cells incubated with secondary antibodies alone after 24
hr in differentiation media (DM).
(C) After 24 hr in DM, wild-type cells were immunostained with an antibody against IL-4R and representative images are shown. Bar: 60 m.
(D) At days 8 and 14 after injury, wild-type regenerating muscle sections were immunostained with an antibody against IL-4. Asterisks indicate
the same myofibers in both fluorescent and haematoxilyn and eosin (H&E) stained images. Regenerating muscle sections at day 8 after injury
from wild-type mice incubated with secondary antibodies alone and from IL-4/ mice incubated with IL-4 antibodies are shown. Bar: 60 m.
(E) mRNA expression for IL-4R, IL-13R1, IL-13R2, and c was examined by RT-PCR in cells after 0, 24, and 48 hr in DM. Macrophage
mRNA was included as a control for IL-4R, IL-13R1, and c, and mRNA from the glioblastoma cell line U251 was included as a control for
IL-13R2. Representative ethidium bromide staining of agarose gel is shown with 18S rRNA as an internal control. Data are indicative of
results from three independent experiments.
cells are small and thin as compared to wild-type myo- nuclei. Thus, the reduced size of the mutant myotubes
correlates with a decrease in the number of nuclei withintubes (Figure 5E). The vast majority of IL-4/ (84%) and
IL-4R/ (91%) myotubes contain two to four nuclei, the cells similar to that observed in vivo. This phenotype
of IL-4/ muscle cells can be rescued by retroviral ex-whereas wild-type cultures contain an equal proportion
of myotubes with two to four nuclei and those with 5 pression of IL-4 (Figure 5F). In addition, retroviral overex-
Cell
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Figure 5. Reduced Myofiber Size in IL-4/ and IL-4R/ TA and Soleus Muscles Is Muscle Cell Intrinsic
(A) Representative sections of wild-type, IL-4/, and IL-4R/ TA muscles are shown. Bar: 60 m. Data for myofiber cross-sectional areas
(XSA) are mean  standard error; n 	 3 for wild-type, n 	 7 for IL-4/, and n 	 4 for IL-4R/.
(B) Frequency histograms showing the distribution of myofiber XSA in wild-type (n 	 256), IL-4/ (n 	 731), and IL-4R/ (n 	 482) Tibialis
anterior (TA) muscles (left) and wild-type (n 	 447), IL-4/ (n 	 1060), and IL-4R/ (n 	 726) soleus muscles (right).
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pression of IL-4 in wild-type cells augments myotube membrane fusion (Wakelam, 1985). Of the limited num-
ber of molecules known to regulate muscle cell fusionsize and myonuclear number (Figure 5F). Therefore,
these data further support a role for IL-4 in the myo- in mammals, the majority of these molecules mediate
the myoblast-myoblast fusion that forms a myotubenuclear accretion that occurs in nascent myotubes.
(Wakelam, 1985; Rosen et al., 1992; Yagami-Hiromasa
et al., 1995; Barnoy et al., 1996; Gorza and Vitadello,IL-4 Acts as a Recruitment Factor for Muscle-Cell
Fusion during Growth 2000). Previous studies of NFATc2/ muscle cells sug-
gested that the initial fusion of myoblasts that formsOur data suggest that IL-4 is secreted by myotubes
and recruits further cell fusion during muscle growth. small nascent myotubes is distinct from the subsequent
fusion of differentiated muscle cells with myotubes dur-However, the cellular target of IL-4 (unfused mono-
nucleated cells versus myotube) is not known. If the ing muscle growth (Horsley et al., 2001). This model
is also supported by recent data from Drosophila thatunfused cells are the target of IL-4, IL-4R/ mono-
nucleated cells should not be recruited to fuse with wild- identified rolling pebbles as a molecule that is required
for fusion of myoblasts with the growing myofiber (Rautype nascent myotubes. To test this hypothesis, wild-
type nascent myotubes were cocultured with IL-4R/ et al., 2001). Here, we demonstrate that the second
phase of myoblast fusion that occurs with myotubes ismononucleated cells. To identify each cell population,
cells were stained with CellTracker fluorescent dyes that dependent on IL-4 and the IL-4R subunit of the IL-4
receptor (Figure 7). Data in support of this model arehave been used previously for cell-fusion studies
(Wunschmann and Stapleton, 2000; Huerta et al., 2002). discussed below. Together, these data further demon-
strate that mechanisms that control myoblast-myoblastCoculture of wild-type nascent myotubes with mono-
nucleated wild-type cells results in 89% of myotubes fusion are distinct from mechanisms that regulate myo-
blast fusion with myotubes in mammals.with both fluorescent labels (Figure 6), demonstrating
efficient cell mixing and cell fusion in the assay. In con- To our knowledge, our data are the first description
of IL-4 expression by a nonimmune cell and suggesttrast, coculture of wild-type myotubes with IL-4R/
mononucleated cells results in only 14% of the myo- that regulation of IL-4 expression by NFATc2 also occurs
in nonlymphoid cells. The regulation of IL-4 expressiontubes with dual label, suggesting that IL-4R/ cells
have a defect in their ability to fuse with wild-type na- in T cells is complex as multiple NFAT isoforms,
NFATc1–NFATc3, seem to control IL-4 expressionscent myotubes. To determine if IL-4 also acts on myo-
tubes, IL-4R/ nascent myotubes were cocultured (Hodge et al., 1996; Monticelli and Rao, 2002; Rengara-
jan et al., 2002). Skeletal muscle expresses NFATc1–with wild-type mononucleated cells. The majority of IL-
4R/ myotubes contain both labels, indicating that NFATc3 in both myoblasts and myotubes (Abbott et al.,
1998), and the expression of NFATc1 and NFATc3 iswild-type mononucleated cells can fuse with IL-4R/
myotubes. Interestingly, these chimeric myotubes are unaffected in NFATc2/ muscle cells (Horsley et al.,
2001). Here, we demonstrate that NFATc2/ musclelarger than IL-4R/ myotubes. We also cocultured IL-
4R/ nascent myotubes with IL-4R/ mononucleated cells do not express IL-4 (Figures 3A and 3B), and the
expression of recombinant NFATc2 restores expressioncells to confirm the defect in the recruitment of IL-4R/
muscle cells. Consistent with the phenotype of IL-4R/ of IL-4 (Figure 3C). The timing of IL-4 expression (Figure
4A) also correlates with NFATc2 activation during myo-myotubes, few IL-4R/ myotubes contain dual label
when cultured with IL-4R/ mononucleated cells, fur- genesis (Abbott et al., 1998). Together, these data indi-
cate that NFATc2 is the primary NFAT isoform responsi-ther suggesting that IL-4R/ muscle cells are unable
to fuse with nascent myotubes. Together, these data ble for IL-4 expression in skeletal muscle. Whether other
NFAT isoforms regulate IL-4 expression in concert withindicate that mononucleated cells are the target of IL-4,
leading to their recruitment and fusion with nascent NFATc2 in muscle is unknown.
The induction of IL-4 expression by NFATc2 promotesmyotubes.
cell fusion, leading to muscle growth. Previously, we
demonstrated that NFATc2 is required for the nuclearDiscussion
addition or cell fusion following myoblast differentiation
(Horsley et al., 2001) and initial myotube formation (Fig-Myoblast fusion is required for skeletal myogenesis as
it allows the formation and growth of multinucleated ure 1A). Here, a target of NFATc2 in skeletal muscle,
IL-4, also regulates cell fusion. Media from wild-typemyotubes. This process requires multiple steps involv-
ing cell migration, alignment, recognition, adhesion, and myotube cultures induces nuclear addition in NFATc2/
(C) A representative wild-type myofiber immunostained with an antibody against dystrophin (red) and stained with DAPI (blue) illustrates the
myonuclear number assay. The number of DAPI-stained nuclei within the dystrophin positive sarcolemma (arrow) were counted in soleus
muscles from wild-type and IL-4/ mice and expressed per 100 myofibers. Arrowhead indicates a nucleus outside the myofiber. Bar: 20 m.
Data are mean  standard error; n 	 3 for each genotype.
(D) The XSA of regenerating TA myofibers was determined at various time points after injury. Data are mean  standard error; n 	 4–7 for
each genotype.
(E) Wild-type, IL-4/, and IL-4R/ myoblasts were induced to differentiate in differentiation media (DM) for 48 hr. Bar: 60 m. Myonuclear
content was examined as in Figure 1B. Data are mean  standard error of three independent cell isolates.
(F) Wild-type or IL-4/ myoblasts were infected with either a control retrovirus (Cntl) or a retrovirus expressing IL-4 (IL-4) and induced to
differentiate for 48 hr. Bar: 30 m. Myotube cultures were analyzed as in Figure 1B. Data are mean  standard error of three independent
cell isolates (*indicates significantly different, p  0.05).
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Figure 6. IL-4 Acts on Myoblasts to Induce Myonuclear Accretion in Myotubes
(A) Wild-type nascent myotubes (NMt) were cocultured for 24 hr in differentiation media (DM) with either wild-type or IL-4R/ differentiated,
mononucleated muscle cells (Mono). In addition, IL-4R/ NMt were cocultured for 24 hr in DM with either wild-type or IL-4R/ differentiated,
mononucleated cells. Label colors represent the particular CellTracker dye used to stain each cell type. Bar: 60 m.
(B) The percentage of myotubes containing dual label was determined and expressed as a percentage of the total myotubes analyzed (100).
Data are the mean  standard error of three independent cell isolates (*indicates significantly different, p  0.05).
myotubes (Figure 1B), which is blocked with the addition expression is required for cell fusion with nascent myo-
tubes during development (Figures 5A–5C) and regener-of antibodies against IL-4 (Figure 2D). Likewise, addition
of exogenous IL-4 rescues defects in myonuclear num- ation (Figure 5D), but whether IL-4 regulates nuclear
accretion that occurs with hypertrophy (Rosenblatt andber (Figure 2A). Furthermore, the phenotype of IL-4/
muscle cells also supports a role for IL-4 in the regulation Parry, 1992) or recovery from atrophy (Mitchell and Pav-
lath, 2001) is unknown.of cell fusion during muscle growth in vivo and in vitro.
IL-4/ myotubes and myofibers form but are reduced To control cell fusion, IL-4 acts through the IL-4R on
myoblasts not myotubes (Figure 7). Both myoblasts andin size likely due to a decreased number of myonuclei
(Figure 5). Expression of recombinant IL-4 induces nu- myotubes express the IL-4R subunit of the IL-4R (Fig-
ures 4C and 4E), and IL-4R is required for muscleclear accretion in wild-type and IL-4/ myotubes (Figure
5F). Interestingly, these myotubes expressing recombi- growth (Figure 5) and likely paired with the IL-13R1
subunit (Figure 4E). Myoblasts that lack IL-4R cannotnant IL-4 demonstrate a branched appearance, sug-
gesting that overexpression of IL-4 leads to cell fusion be recruited by nascent myotubes that secrete IL-4 (Fig-
ure 6). However, IL-4R/ nascent myotubes can recruitat multiple locations along the myotube. Clearly, IL-4
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the fusion of myoblasts with myotubes. In addition, in
Drosophila, nascent myotubes express a cytoplasmic
protein, rolling pebbles, that is required for fusion of
myoblasts with growing muscle cells (Rau et al., 2001).
Since homologs of NFATc2 are not expressed in Dro-
sophila, the control of cell fusion by the NFATc2 pathway
may have evolved in higher eukaryotes to regulate the
plasticity of muscle growth, allowing maintenance of
muscle mass over an extended lifespan and the growth
of muscles containing multiple myofibers.
The involvement of IL-4 in regulating cell fusion in
both macrophages and muscle cells suggests that fu-
sion mechanisms are conserved among these cell types.Figure 7. Model for the Role of IL-4 in the Recruitment of Myoblast
Fusion during Muscle Growth To control macrophage fusion, IL-4 induces expression
Myoblast fusion occurs in two stages. In the first phase, a subset of the integrins 
1 and 
2 (McNally and Anderson, 2002).
of differentiated myoblasts fuse together to form a nascent myotube 
3 integrin is also regulated by IL-4 in macrophages
with a limited number of nuclei. A second phase of myoblast fusion (Kitazawa et al., 1995). Thus, IL-4 may mediate the fusion
occurs with nascent myotubes. Under the control of NFATc2, IL-4
of myoblasts by increasing the expression of cell adhe-is secreted by nascent myotubes and induces this second phase
sion molecules. In fact, IL-4 can induce the expressionof fusion through IL-4R on myoblasts. This action allows the accre-
of intracellular adhesion molecule-1 (ICAM-1) on myo-tion of nuclei within nascent myotubes and, along with protein accu-
mulation, the formation of a large, mature myotube. blasts (Marino et al., 2001). Intriguingly, the expression
of VCAM-1, which is specifically expressed on myo-
blasts and is required for myotube formation in vitro
(Rosen et al., 1992), is controlled by IL-4 in vascularcell fusion of wild-type myoblasts. Together, these data
endothelial cells (Schleimer et al., 1992) and smoothindicate that signaling via the IL-4R in myoblasts is re-
muscle cells (Barks et al., 1997). In addition to the induc-quired for cell fusion with nascent myotubes. While the
tion of adhesion molecules, IL-4 stimulates chemotaxissignaling pathways downstream of the IL-4R in skeletal
of osteoblasts (Lind et al., 1995), suggesting that IL-4muscle are unknown, several targets have been identi-
may also regulate myoblast chemotaxis during myotubefied in other cell types, including Janus kinases, insulin
growth. The mechanisms by which IL-4 induces cellreceptor substrate-1/2, phosphoinositide-3-kinase
fusion are currently under investigation.[PI(3)K], MAP kinase, and Stat-6 (Nelms et al., 1999).
As a molecular signal that promotes fusion of myo-The activation of PI(3)K is of particular interest given
blasts with myotubes, IL-4 treatment may be useful clini-recent data implicating this pathway in muscle growth
cally in muscle disorders. Induction of endogenous myo-downstream of IGF-1 (Rommel et al., 2001).
blast fusion may ameliorate muscle diseases or speedThe expression of IL-4 is restricted to a subpopulation
recovery of muscle atrophy and/or injury. Also, inducingof multinucleated myotubes (Figure 4). Heterogenity in
the fusion of exogenous myoblasts (Blau and Springer,muscle cells is likely a common mechanism to control
1995) or stem cells may improve gene therapy protocolscell fusion. In Drosophila, unique gene expression pat-
utilizing transplanted cells to treat muscle disorders.terns in myoblasts form two populations, founder myo-
Further work determining the molecular pathways byblasts and fusion competent myoblasts, resulting in
which IL-4 induces myoblast fusion will aid in the devel-asymmetric fusion of these myoblast populations (Tay-
opment of possible clinical therapies.lor, 2002). Our data suggest that heterogeneity during
cell fusion also exists in mammalian muscle cells and
Experimental Proceduresmay allow IL-4 to act as either a general or a specific
signal for fusion. As a general signal, IL-4 may lead to
Animalsenhanced fusion competency of muscle cells, regulating
Wild-type Balb/c controls and NFATc2/ mice were generated by
fusion with both IL-4 expressing and nonexpressing heterozygous mating of mice carrying a targeted disruption in the
myotubes. To direct specific fusion, IL-4 may recruit the NFATc2 gene (Hodge et al., 1996). Mice were genotyped by PCR
analyses of tail DNA (Hodge et al., 1996). Wild-type Balb/cJ, IL-4/fusion of myoblasts with the distinct subset of myotubes
and IL-4R/ were purchased from Jackson Laboratories. Adultthat secrete IL-4, allowing other myotubes to grow
male mice between 8–12 weeks of age were used for all studies.through alternative signals.
All animals were handled in accordance with the institutional guide-Our data support a role for multinucleated muscle
lines of Emory University.
cells in the promotion of cell fusion and growth (Figure
7). Other studies also demonstrate that multinucleated
Primary Muscle Cell Culture and Cytokine Treatment
muscle cells can control fusion. During embryogenesis, Primary cultures were derived from tibialis anterior (TA) muscles of
subpopulations of myoblasts fuse with specific myo- wild-type, NFATc2/, IL-4/, and IL-4R/ mice 2 days after in-
duced muscle damage (Pavlath et al., 1998), and myoblasts weretubes in the development of primary and secondary
purified to 99% in selective media (Rando and Blau, 1994). Allmyofibers (Harris et al., 1989; Zhang and McLennan,
experiments were performed with independent cell isolates from1995). In addition, unidentified secreted proteins pro-
three animals for each genotype. Myoblasts were grown in growthduced by myotubes can control cell fusion (Konigsberg,
media (GM: Ham’s F10, 20% fetal bovine serum, 5 ng/ml bFGF, 100
1971; Doering and Fischman, 1977; Yeoh and Holtzer, U/ml penicillin G, and 100 g/ml streptomycin) on collagen-coated
1977). To our knowledge, our data are the first to identify dishes in a humidified 5% CO2 atmosphere at 37C. Differentiation
was induced by plating 2 105 myoblasts per well of E-C-L (Upstatea secreted protein produced by myotubes that promotes
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Biotechnology) coated 6-well dishes and after 2 hr, switching the total RNA. 18S rRNA was used as control for each sample using
QuantumRNA 18S primers (Ambion). IL-4 cDNA was amplified usingmedia to a low serum, low-mitogen differentiation media (DM:
DMEM, 100 U/ml penicillin G, and 100 g/ml streptomycin) con- Expand High Fidelity PCR system (Roche) by incubation at 94C for
5 min, followed by 35 cycles of 94C for 30 s, 58C for 30 s, 72Ctaining either 2% horse serum or Insulin-Transferrin-Selenium-A
supplement (Gibco) for 48 hr. In experiments using exogenous cyto- for 45 s, and termination at 72C for 5 min. Similar amplification
cycles were performed for the IL-4R, IL-13R1, IL-13R2, and ckines, vehicle (0.1% bovine serum albumin in PBS), IL-4, or IL-13
(R&D Systems) were added to DM and replenished at 24 hr for a receptor subunits with annealing temperatures of 58C for IL-13R1,
IL-13R2, and c, and 56C for IL-4R. For IL-4, 5 l of the initialtotal treatment of 48 hr.
PCR reaction was removed, and PCR reagents were replenished
for a second round of amplification. The amplicons were resolvedConditioned Media Experiments
by electrophoresis on a 1.5% agarose gel and visualized by ethidiumConditioned media (CM) was collected from muscle cells after 24
bromide staining.and 48 hr in DM. In all assays, myoblasts were placed in CM, and
A 10-fold concentration of wild-type and NFATc2/ CM was ana-CM was replenished at 24 hr. All experiments were analyzed after
lyzed for IL-4 levels using Quantikine M-ELISA (R&D Systems) with48 hr of treatment. In control experiments, no differences were ob-
a lower detection limit of 2 pg/ml.served in the formation of wild-type myotubes in wild-type CM com-
pared to DM. Neutralization of CM was performed by treating CM
with rat monoclonal antibodies against either IL-4, IL-13, or their Collection of Muscles and Morphometric Measurements
corresponding control rat IgG antibodies (R&D systems, Sigma). In Collection and analysis of undamaged and regenerating muscles
control experiments, addition of IL-4 together with antibodies were performed as previously described (Horsley et al., 2001). Ana-
against IL-4 abolished the ability of IL-4 to induce growth of tomical markers were used to find the same region in different sam-
NFATc2/ myotubes. ples, and these sections were subsequently used for analyses of
myofiber cross-sectional area. To examine the growth of regenerat-
ing muscles, TA muscles were subject to a standardized local freezeFusion Assays
damage (Pavlath et al., 1998) and the cross-sectional area of regen-After 48 hr in DM or CM, cells were fixed and immunostained with
erating myofibers was measured. The cross-sectional area of un-antibodies against embryonic myosin heavy chain (F1.652, Develop-
damaged and regenerating myofibers in the TA was expressed asmental Studies Hybridoma Bank, Iowa City, Iowa) as previously
a mean of the total fibers analyzed (75-225). The cross-sectionaldescribed (Horsley et al., 2001). The fusion index was determined
area was also analyzed in the undamaged TA and soleus as a distri-by dividing the number of nuclei in myotubes (2 nuclei) by the
bution and expressed as a percentage of the total number of myofi-total number of nuclei analyzed (100–250). Fusion was also analyzed
bers analyzed. All photography was performed on an Axioplan mi-by performing nuclear number assays (Horsley et al., 2001). The
croscope (Zeiss) equipped with a video camera and Adobenumber of nuclei in individual myotubes was counted for 50–100
Photoshop and Scion Image software. All cross-sectional area mea-myotubes. Myotubes were grouped into two categories: those with
surements were performed using Scion Image software.two to four nuclei and those with five or more nuclei. The percentage
of myotubes in each category was calculated.
In Vivo Nuclear Number Assay
Myonuclei were quantified as described previously (Horsley et al.,DNA Quantification
2001). Briefly, soleus muscles were incubated in antibody againstAfter 48 hr in DM, cells were collected by scraping and centrifuged
dystrophin (MANDYS8, Sigma; 1:400) for 1 hr at room temperature.at 10,000  g at 4C. Cells were resuspended in 250 l of saline-
After washing in TNT (0.1 M Tris-HCl [pH 7.5], 0.15M NaCl, andphosphate buffer (0.05 M NaPO4 and 2 M NaCl [pH 7.4]) and frozen.
0.05% Tween 20), the sections were incubated in Texas red conju-Samples were thawed, sonicated for 15 s, and a 50 l aliquot of
gated goat anti-mouse IgG (Cappel, Durham, NC; 1:50). After furthereach sample was added to the buffer containing 0.5 g/ml Hoechst
washing in TNT, the sections were mounted in Vectashield mounting33258 (Molecular Probes). DNA concentration was determined as
media containing DAPI (Vector Labs). Nuclei within the dystrophin-previously described (Mitchell and Pavlath, 2001).
positive sarcolemma were counted for 100–150 myofibers, and the
number of myonuclei was expressed per 100 myofibers.Retroviral Plasmids, Production, and Infection
The NFATc2 construct has been previously described (Horsley et
Cellular Analyses of IL-4 and IL-4R Expressional., 2001). A retroviral vector expressing full-length mouse IL-4 was
At 12 hr intervals in DM, muscle cells were fixed with ice-cold metha-created by excision of IL-4 cDNA from a vector containing the full-
nol for 10 min at room temperature. After washing in PBS, nonspe-length IL-4 cDNA (gift from Dr. M. Brown) by BamHI and SalI to
cific binding was blocked with TNB and cells were incubated withcreate a 0.6 kb product. The IL-4 cDNA was then cloned into a basic
a rat monoclonal antibody against IL-4 (500ng/ml) or IL-4Rretroviral vector in which expression of IL-4 is driven by the retroviral
(500ng/ml) (R&D Systems) at 4C overnight. After washing in TNT, the5-LTR. Production of infectious retrovirus and infection of primary
cells were incubated in biotin conjugated goat anti-rat IgG (Jacksonmyoblasts were performed as previously described (Abbott et al.,
Laboratories; 1:250) for 1 hr at room temperature, washed in TNT,1998). Cells were subject to two rounds of infection with an efficiency
and incubated in HRP-strepavidin (1:50) (NEN Life Sciences) for 30of gene transfer of90% based on visualization of green fluorescent
min at room temperature. After further washes in TNT, the cells wereprotein.
incubated in the TSA green reagent (NEN Life Sciences) diluted 1:50
in amplification buffer for 5 min at room temperature, followed byRT-PCR and Protein Analyses
a final wash in TNT. The number of IL-4-positive cells was quantifiedRNA was isolated using Trizol Reagent (Life Technologies) from
and expressed as a percentage of the total number of cells analyzedmuscle cells. RT-PCR was performed for each sample using primers
(100–200).specific for IL-4 (accession number: NM_021283) (sense, 5-AACCC
Sections of regenerating TA muscles were fixed in 3.7% formalde-CCAGCTAGTTGTCATCCTG-3; antisense, 5-CATCGAAAAGCCC
hyde, treated with 0.3% H2O2 in PBS, washed in PBS, blocked withGAAAGAGTCTC-3), IL-4R (accession number: NM_010557) (sense,
TNB, and incubated with primary and secondary antibodies as de-5-TGTAGCCCGGCCCCAAATCC-3; antisense, 5-GGCGGCACCC
scribed above. Sections were mounted in Vectashield mountingTGCTTCACTG-3), IL-13R1 (accession number: S80963) (sense,
media containing DAPI (Vector Labs). No staining was observed in5-CCGCGGCACAGAAGTTCAGC-3; antisense, 5-ACAGCGGACTC
control sections incubated with secondary antibodies alone or inAGGATCACCTTCA-3), IL-13R2 (accession number: NM_008356)
IL-4/ muscles.(sense, 5-GAGCACACCTGGAGGACCCATTCC-3; antisense, 5-GGC
CCTGTGTAACCTTCCCAACATTC-3), and c (accession number:
NM_013563) (sense, 5-GAGCCGCTATAACCCAATCTGTGG-3; Cell Mixing Experiments
Cells were plated at 2 105 cells per well of a 6-well plate to produceantisense, 5-GGGAGGCCAGTAAGGGCTATGC-3). All primer pairs
span intron/exon boundaries to control for DNA contamination in nascent myotubes, and cells were plated at 1  105 cells per well
to produce differentiated, mononucleated cells. After 24 hr in DM,RNA samples. All RT reactions were performed using 2.5 g of
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nascent myotubes were stained with 0.5 M CellTracker green molecular factor in muscle conditioned medium. Exp. Cell Res. 105,
437–443.CMFDA (5-chloromethyl-7-hydroxycoumarin) (Molecular Probes)
and mononucleated cells were stained with 3M CellTracker orange Donaldson, D.D., Whitters, M.J., Fitz, L.J., Neben, T.Y., Finnerty, H.,
CMTMR (5-(and-6)-(((4-chloromethyl) benzoyl) amino) tetrameth- Henderson, S.L., O’Hara, R.M., Jr., Beier, D.R., Turner, K.J., Wood,
ylrhodamine) (Molecular Probes) for 10 min at 37C. Cells were C.R., and Collins, M. (1998). The murine IL-13 receptor alpha 2:
washed twice with PBS, trypsinized, and plated at equal cell number molecular cloning, characterization, and comparison with murine
with a final cell number of 2  105 in each well of a 6-well plate. IL-13 receptor alpha 1. J. Immunol. 161, 2317–2324.
After 24 hr, cocultures were fixed with 3.7% formaldehyde. The
Gorza, L., and Vitadello, M. (2000). Reduced amount of the glucose-
presence of dual label was analyzed in 50–100 myotubes with 
regulated protein GRP94 in skeletal myoblasts results in loss of
three to four nuclei and was only observed in cells with multiple
fusion competence. FASEB J. 14, 461–475.
nuclei. In control experiments, wild-type cells showed 100% staining
Harris, A.J., Duxson, M.J., Fitzsimons, R.B., and Rieger, F. (1989).efficiency with no deleterious effects on cell fusion.
Myonuclear birthdates distinguish the origins of primary and sec-
ondary myotubes in embryonic mammalian skeletal muscles. Devel-
Statistics
opment 107, 771–784.
To determine significance between two groups, comparisons were
Hodge, M.R., Ranger, A.M., Charles de la Brousse, F., Hoey, T.,made using Student’s t tests. Analyses of multiple groups were
Grusby, M.J., and Glimcher, L.H. (1996). Hyperproliferation and dys-performed using one-way ANOVA with Bonferroni’s posttest using
regulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4,GraphPad Prism version 3.0a for Macintosh (GraphPad Software).
397–405.For all statistical tests, the 0.05 level of confidence was accepted
Horsley, V., Friday, B.B., Matteson, S., Kegley, K.M., Gephart, J.,for statistical significance.
and Pavlath, G.K. (2001). Regulation of the growth of multinucleated
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